Inherited Platelet Disorders and Use of Genetic Testing.
Abstract
Inherited platelet disorders (IPDs) are caused by pathogenic variants in genes responsible for megakaryocyte and platelet biology, leading to qualitative and quantitative platelet defects. Advances in high-throughput sequencing plus variant-curation expertise and detailed clinical evaluation have led to the identification of about 70 genes associated with IPDs and enabled the diagnosis of about half of the IPDs. Genetic testing in clinical settings is becoming more accessible and affordable, while additional gene variants continue to be discovered. Communication of genetic results to families and the implementation of personalized therapies underpin current IPD management.